Covestor’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1K Buy
31
+8
+35% +$159 ﹤0.01% 2163
2025
Q4
$0 Sell
23
-329
-93% -$6.83K ﹤0.01% 2764
2025
Q3
$10K Sell
352
-45
-11% -$1.39K 0.01% 1620
2025
Q2
$12K Buy
397
+88
+28% +$2.5K 0.01% 1493
2025
Q1
$9K Buy
309
+284
+1,136% +$8.99K 0.01% 1589
2024
Q4
$1K Buy
25
+16
+178% +$598 ﹤0.01% 2149
2024
Q3
$0 Sell
9
-218
-96% -$8.96K ﹤0.01% 2803
2024
Q2
$11K Buy
227
+12
+6% +$552 0.01% 1498
2024
Q1
$10K Sell
215
-1,550
-88% -$75.9K 0.01% 1621
2023
Q4
$94K Buy
1,765
+18
+1% +$910 0.06% 535
2023
Q3
$103K Buy
1,747
+158
+10% +$9.88K 0.08% 398
2023
Q2
$100K Sell
1,589
-13
-0.8% -$828 0.08% 443
2023
Q1
$101K Buy
1,602
+2
+0.1% +$119 0.09% 368
2022
Q4
$85K Buy
1,600
+180
+13% +$9.75K 0.07% 485
2022
Q3
$80K Buy
1,420
+494
+53% +$32.7K 0.07% 474
2022
Q2
$67K Sell
926
-1
-0.1% -$74 0.05% 638
2022
Q1
$74K Buy
927
+446
+93% +$40.2K 0.05% 673
2021
Q4
$49K Buy
+481
New +$48K 0.07% 559

Other funds holding USNA

Covestor's USNA Position: Q1 2026 in Review

Covestor increased its Usana Health Sciences (USNA) stake by 35% in Q1 2026, buying an estimated $159 and bringing the position to 31 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2163.

Covestor first reported a position in USNA in Q4 2021 and has held it in 18 quarters since. The position peaked at $103K in Q3 2023. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Covestor held 31 shares of Usana Health Sciences worth $1K as of Q1 2026.
  • Covestor bought 8 Usana Health Sciences shares in Q1 2026, an estimated $159.
  • Usana Health Sciences made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2163 holding.
  • Covestor first reported a position in Usana Health Sciences in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Usana Health Sciences position peaked at $103K in Q3 2023.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.